Rethinking How Life Sciences Organizations Approach AI – Mathias Cousin of Deloitte
This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…


Read the Emerj team’s latest coverage on AI use-cases and trends in banking.
This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

Across regulated and asset-intensive industries, AI adoption is shaped by factors beyond technical feasibility. Organizations now seek to deploy AI systems…

Bristol Myers Squibb is a global biopharmaceutical leader dedicated to delivering innovative medicines across oncology, hematology, immunology, cardiovascular disease, and neuroscience.…

This article is sponsored by NLP Logix and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

This interview analysis is sponsored by AnswerRocket and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

Clinical trials comprise the most significant portion of drug development costs. In some cases, drug R&D costs can approach as high…

SMBs are overwhelmed by multi-step operational work that drains time and headcount. Global trade processes remain slow, fragmented, and opaque. For…
